Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression

被引：7

作者：

Pirat, Celine ^{[1
]}

Dacquet, Catherine ^{[2
]}

Leclerc, Veronique ^{[1
]}

Hennuyer, Nathalie ^{[3
]}

Beucher-Gaudin, Monique ^{[2
]}

Zanirato, Ghislaine ^{[2
]}

Geant, Anne ^{[2
]}

Staels, Bart ^{[3
]}

Ktorza, Alain ^{[2
]}

Farce, Amaury ^{[4
]}

Caignard, Daniel-Henri ^{[5
]}

Berthelot, Pascal ^{[1
]}

Lebegue, Nicolas ^{[1
]}

机构：

[1] Univ Lille, INSERM, CHU Lille, UMRS 1172,JPArc,Ctr Rech Jean Pierre AUBERT Neurs, F-59000 Lille, France

[2] Inst Rech Servier, Pole Innovat Therapeut Malad Metab, F-92150 Suresnes, France

[3] Univ Lille, INSERM, CHU Lille, Inst Pasteur Lille,U1011,EGID, F-59000 Lille, France

[4] Univ Lille, INSERM, CHU Lille, U995,LIRIC, F-59000 Lille, France

[5] Inst Rech Servier, Pole Expertise Chim Therapeut, 125 Chemin Ronde, F-78390 Croissy Sur Seine, France

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2017年 / 137卷

关键词：

Diabetes; PPAR; SIRT1; SGK1; Calorie restriction; Resveratrol; Body-weight gain; PROLIFERATOR-ACTIVATED RECEPTORS; PPAR-GAMMA; INSULIN-RESISTANCE; UP-REGULATION; RESVERATROL; CELL; VALIDATION; POTENT; COMPLICATIONS; METABOLITES;

D O I：

10.1016/j.ejmech.2017.06.006

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of benzothiazol-2-one containing alpha-ethoxyphenylpropionic acid derivatives incorporating resveratrol or butein scaffolds were designed as fused full PPAR gamma agonist ligands and SIRT1-activating compounds for the treatment of type 2 diabetes (T2D) and its complications. Compound 14d displayed the best in vitro pharmacological profile with full PPAR gamma agonist activity (Emax = 98%, EC50 = 200 nM), SIRTI enzymatic activation (+128%) and SGK1 expression inhibition (- 57%) which is known to limit side effects as fluid retention and body-weight gain. Compound 14d showed high efficacy in an ob/ob mice model with significant decreases in serum triglyceride, glucose and insulin levels but mostly with limited body-weight gain by mimicking calorie restriction (CR) and inhibiting SGKI expression. (C) 2017 Elsevier Masson SAS. All rights reserved.

引用

页码：310 / 326

页数：17

共 86 条

[1] The First Approved Agent in the Glitazar's Class: Saroglitazar [J].

Agrawal, Ritesh .

CURRENT DRUG TARGETS, 2014, 15 (02) :151-155

[2]

[Anonymous], 1699, SYBYL 6.9.1, Patent No. 631442913

[3]

[Anonymous], 2010, COMPR ORG NAME REACT, V145, P660

[4]

Bailey Clifford J, 2007, Diab Vasc Dis Res, V4, P161

[5] Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat [J].

Barzilai, N ;

Banerjee, S ;

Hawkins, M ;

Chen, W ;

Rossetti, L .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07) :1353-1361

[6] The heck reaction as a sharpening stone of palladium catalysis [J].

Beletskaya, IP ;

Cheprakov, AV .

CHEMICAL REVIEWS, 2000, 100 (08) :3009-3066

[7] Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes [J].

Benardeau, Agnes ;

Benz, Joerg ;

Binggeli, Alfred ;

Blum, Denise ;

Boehringer, Markus ;

Grether, Uwe ;

Hilpert, Hans ;

Kuhn, Bernd ;

Maerki, Hans Peter ;

Meyer, Markus ;

Puentener, Kurt ;

Raab, Susanne ;

Ruf, Armin ;

Schlatter, Daniel ;

Mohr, Peter .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) :2468-2473

[8] Metabolic effects of resveratrol: addressing the controversies [J].

Bitterman, Jacob L. ;

Chung, Jay H. .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (08) :1473-1488

[9] Novel 1,3-dicarbonyl compounds having 2(3H)-benzazolonic heterocycles as PPARγ agonists [J].

Blanc-Delmas, Elodie ;

Lebegue, Nicolas ;

Wallez, Valerie ;

Leclerc, Veronique ;

Yous, Said ;

Carato, Pascal ;

Farce, Amaury ;

Bennejean, Caroline ;

Renard, Pierre ;

Caignard, Daniel-Henri ;

Audinot-Bouchez, Valerie ;

Chomarat, Pascale ;

Boutin, Jean ;

Hennuyer, Nathalie ;

Louche, Katie ;

Carmona, Maria Carmen ;

Staels, Bart ;

Penicaud, Luc ;

Casteilla, Louis ;

Lonchampt, Michel ;

Dacquet, Catherine ;

Chavatte, Philippe ;

Berthelot, Pascal ;

Lesieur, Daniel .

BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (22) :7377-7391

[10] The Sir2 family of protein deacetylases [J].

Blander, G ;

Guarente, L .

ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 :417-435

← 1 2 3 4 5 6 7 8 9 →